Pricing Log in Create free account

Adagene Inc. Sponsored ADR (ADAG) vs MacroGenics, Inc. (MGNX)

Adagene Inc. Sponsored ADR and MacroGenics, Inc. are both Biotechnology companies. MacroGenics, Inc. is the larger, with a market value of $148.4M against $134.3M — 1.1× the size. Across the 9 metrics below, Adagene Inc. Sponsored ADR leads on 7 and MacroGenics, Inc. on 2.

Valuation

Metric ADAG MGNX Biotechnology median
P/E — n/m 10.60
P/S — 0.88 9.40
P/B n/m 3.46 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.61 0.66
EV/Sales n/m (0.11) 9.02
Earnings yield — (9.44%) (32.88%)
Free cash flow yield 0.00% (44.23%) (23.13%)

Profitability

Metric ADAG MGNX Biotechnology median
Gross margin — 85.23% 68.51%
Operating margin — (20.45%) 0.00%
Net margin — (8.70%) 0.00%
Free cash flow margin 0.00% (39.08%) 0.00%
Return on equity 0.00% (32.61%) (51.96%)
Return on assets 0.00% (4.94%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADAG MGNX Biotechnology median
Revenue growth (TTM) — 1.32% 6.76%
EPS growth (last fiscal year) 49.15% (10.28%) 29.88%
Revenue growth, 5-year CAGR 61.38% 7.35% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADAG MGNX Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 5.02 2.96 4.97
Net debt to EBITDA 3.46 2.82 1.01

Dividend

Metric ADAG MGNX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADAG MGNX Biotechnology median
Market cap 134.28m 148.42m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack